Literature DB >> 17976254

Rhinolithiasis: clinical, radiological, and mineralogical features.

Nadir Yildirim1, Atilla Arslanoglu, Murat Sahan, Altan Yildirim.   

Abstract

BACKGROUND: Rhinolithiasis is a rare and under-diagnosed clinical entity whose etiology and pathogenesis is poorly understood.
OBJECTIVE: The objective of the study is to review the clinical and radiologic features of rhinolithiasis and mineralogical-chemical composition of the rhinoliths with the aim of shedding light on its etiology and pathogenesis.
METHODS: Our subjects consisted of 8 rhinolithiasis cases. Clinical presentations, signs, and symptoms of the patients with radiologic findings are presented, and X-ray diffraction analyses of the stones were carried out to assess their mineralogical composition.
RESULTS: Nasal obstruction appeared to be the chief symptom, followed by nasal discharge and facial pain. Neither exogenous nor endogenous nidi were identified in any of the cases. Mineralogical analyses of the rhinoliths revealed Whitlockite [(Ca,Mg)3 (PO4)2] in one and Dahllite [Ca5 (PO4,CO3)3OH] in 7 cases.
CONCLUSION: We hypothesized that some substances or organic objects form the nidi of the rhinoliths and are disintegrated over the course of mineral precipitation. This hypothesis was supported by radiologic and microscopic findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17976254     DOI: 10.2500/ajr.2007.21.3112

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  3 in total

1.  A bolt from the blew: rhinolith in the nose for more than 80 years.

Authors:  Mohammad Shebli Kermanshahi; Patrick Jassar
Journal:  BMJ Case Rep       Date:  2012-11-27

2.  The rhinolith-a possible differential diagnosis of a unilateral nasal obstruction.

Authors:  Detlef Brehmer; Randolf Riemann
Journal:  Case Rep Med       Date:  2010-06-17

3.  Asymmetric adenoid hypertrophy in a patient with ipsilateral rhinolithiasis: an overlooked entity?

Authors:  C Kazikdas; S Gode; M Demirci
Journal:  J Surg Case Rep       Date:  2011-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.